zepbound shortage 2025 - Health Topics
Drugmakers say the supply of the popular weight loss medications Wegovy and Zepbound is now ample, but pharmacies claim the FDA rushed the call and ignored evidence of ongoing shortages. Non-FDA-approved GLP-1 receptor agonists remain largely available despite recent resolutions to drug shortages, data at the Obesity Medicine Association’s annual meeting indicate. Michael J.
Understanding the Context
DiStefano ... With weight loss drugs such as Ozempic and Zepbound rising in popularity, officials caution against using unauthorized alternatives, which pose serious health risks. Business Wire: GoodRx to Expand Employer-Sponsored Access to Zepbound ® KwikPen ® GoodRx to collaborate with Eli Lilly to expand employer-sponsored access to Zepbound® KwikPen®, an FDA-approved dual GIP and GLP-1 obesity treatment Through GoodRx Employer Direct, self-insured ... The Hill on MSN: Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...
Image Gallery
Key Insights
Regeneron’s Chinese partner reported Zepbound-like efficacy in a phase 3 trial, de-risking one part of the Big Biotech’s differentiated play for the obesity market. New York-based Regeneron made a ...